The National Community Pharmacists Association and the National Association of Chain Drug Stores issued the following statement after a final drug pricing rule was released and failed to reform pharmacy direct and indirect remuneration fees, or pharmacy DIR:
"We are disappointed and frustrated that this final rule fails to finalize pharmacy DIR reform as proposed, to the detriment of seniors and community pharmacies. Our organizations have been joined by many pharmacists, pharmacy stakeholder groups, patient advocacy organizations, patients, and members of Congress in advocating that all pharmacy price concessions be included at the point of sale - or eliminated altogether - to provide senior patients with lower costs and pharmacies with more certainty.
"In its proposed rule the administration cited the recent 45,000 percent increase in pharmacy price concessions, an increase that is unsustainable. Pharmacies are in a tenuous situation, and our organizations are exploring all options to accomplish desperately needed reforms to pharmacy DIR. It is necessary for community pharmacies and for the benefit of seniors that this reform take effect as soon as possible."
Pharmacy DIR fees are based on a regulatory loophole that plans have exploited to increase beneficiary drug costs. These fees are being misused by payers to claw back reimbursement to pharmacies for the prescription drugs that they provide to Medicare beneficiaries. For example, payers impose penalties for pharmacies' alleged failure to achieve certain benchmarks - many of which are vague, undefined, inconsistent, unachievable or outside of the control of pharmacies. Misinterpretations of specific terms that are used in the Medicare program related to pharmacy reimbursement and drug pricing have led to these claw-backs, and ultimately to higher out-of-pocket drug costs for patients and increased costs for the government.
VIDEO of United States Senator Lamar Alexander (R-Tenn.) visiting the Neighborhood Health at East Side health center in Nashville, where he learned more about what the center is doing to provide access to health care services in urban, underserved areas of Nashville.
MycoDART, Inc., developer of proprietary DNA tests, announced its second patented assay has been granted a CPT code from the American Medical Association.
Women who consume alcohol during pregnancy -- even in small amounts -- have a 19% greater risk of miscarriage than women who don't use alcohol, according to a new study by Vanderbilt researchers.
Vanderbilt Children's Hospital researchers play key role in groundbreaking study.
Never a dull moment ... the highly regulated nature of the healthcare industry keeps America's health lawyers hopping.
Monroe Carell Jr. Children's Hospital at Vanderbilt has recently welcomed new leaders to oversee specialty programming and again been recognized nationally in multiple specialties.
Local experts offer insight over ongoing coverage concerns for Tennessee children
Innovative initiatives at TriStar Centennial designed to keep mom and baby safe, together.
NeuroSigma recently received FDA clearance for the first device to treat pediatric ADHD, offering providers, patients and parents a new alternative to medication.
Back-to-school season is here, and it's a great time to talk to patients and parents about starting off the year with healthy habits